<
AI
Automation
Science
Innovation
Open Source
Blockchain
Social Media
Startups
Culture
Cloud
>

Destination
Novo Nordisk and Eli Lilly ink deals with Trump to cut weight loss drug prices

Prices of Eli Lilly's and Novo Nordisk's GLP-1 drugs will drop in some cases — in exchange for partially expanded Medicare coverage [...]

Discover Copy
Rating

Innovation

Pricing

Technology

Usability

We have discovered similar tools to what you are looking for. Check out our suggestions for similar AI tools.

Destination
How Ozempic maker Novo Nordisk fell behind Eli Lilly in the weight loss drug race

Novo Nordisk (NVO) makes Ozempic, the best-known GLP-1 drug out today. And until quite recently, the Danish pharma giant consistently led the pack in new prescriptions, becoming virtually synonymous w [...]

Match Score: 186.83

Destination
The best E Ink tablets for 2025

E Ink tablets have always been intriguing to me because I’m a longtime lover of pen and paper. I’ve had probably hundreds of notebooks over the years, serving as repositories for my story ideas, t [...]

Match Score: 167.62

Destination
Eli Lilly's Zepbound beat Novo Nordisk’s Wegovy in a big weight loss drug study

Eli Lilly’s (LLY) and Novo Nordisk’s (NVO) weight loss drugs went head-to-head in a weight loss study for the first time — and Eli Lilly’s drug came out on top.Read more... [...]

Match Score: 163.66

Destination
Eli Lilly and Novo Nordisk are tackling heart health next

After revolutionizing the weight-loss drug market, Novo Nordisk (NVO) and Eli Lilly (LLY) are setting their sights on heart health.Read more... [...]

Match Score: 138.37

Destination
Eli Lilly signs $2.75 billion deal with AI drug developer Insilico Medicine

US pharmaceutical giant Eli Lilly is betting big on AI-driven drug development, signing a $2.75 billion deal with Hong Kong-listed Insilico Medicine.<br /> The article Eli Lilly signs $2.75 bill [...]

Match Score: 103.65

Destination
Eli Lilly stock sinks as pharma misses out on the market rally

Pharma companies were mostly left out of the stock market’s broader rally Monday morning on the news that President Donald Trump will sign an order lowering drug prices.Read more... [...]

Match Score: 102.46

qz
Novo Nordisk says Wegovy shows greater weight loss than Eli Lilly's rival pill

A cross-trial comparison shows Novo's oral semaglutide produced 3.2 percentage points more weight loss than Foundayo, with Eli Lilly's drug seeing significantly higher dropout rates due to s [...]

Match Score: 96.04

Destination
Novo Holdings' earnings nearly doubled in 2024, despite Novo Nordisk's stock slump

Novo Holdings, the controlling shareholder of Ozempic-maker Novo Nordisk (NVO), nearly doubled its annual income and investment returns in 2024.Read more... [...]

Match Score: 95.91

qz
The weight loss drug giants are going in opposite directions

Novo Nordisk invented the modern weight loss drug market with Ozempic. But it's Eli Lilly that is now best positioned to scale that market profitably [...]

Match Score: 93.14